← Eichor
Study identifier: NCT06921148 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Silk Bioprotein as a Wound Dressing for Double-Incision Mastectomy

Condition: Wound Healing  ·  Sponsor: Indiana University

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study will investigate the utility of Silk bioprotein, an FDA-approved and readily available post-surgical dressing, as a wound dressing for patients undergoing double-incision mastectomy for female-to-male gender affirmation surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Ivan Hadad, MD  ·  (317) 944-5000  ·  ihadad@iu.edu

Parhom Towfighi, MD  ·  (317) 944-5000  ·  ptowfigh@iu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Indiana University HealthIndianapolis, Indiana, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06921148